Volume | 514,009 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 1.24 | Mínimo Máximo |
|||||
Minimo del Dia | 0.9736 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
INVO BioScience Inc | INVO | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
1.24 | 0.9736 | 1.24 | 1.00 | 1.07 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
1,529 | 514,009 | US$ 1.08 | US$ 552,805 | - | 0.50 - 8.60 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
18:58:17 | 10 | US$ 1.05 | USD |
Información Financiera INVO BioScience Inc INVO
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
2.47M | 2.47M | - | 3.02M | -8.04M | -3.25 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre INVO BioScience Inc INVO
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
15/5/2024 | 15:51 | Edgar (US Regulatory) | Form 8-K - Current report |
15/5/2024 | 15:15 | GlobeNewswire Inc. | INVO Reports Record First Quarter 2024 Financial Results |
06/5/2024 | 16:30 | Edgar (US Regulatory) | Form 8-K - Current report |
17/4/2024 | 09:25 | AllPennyStocks.com | Micro Cap Massively Bid Up Before Opening Bell |
16/4/2024 | 15:59 | GlobeNewswire Inc. | INVO Reports Fourth Quarter and Full Year 2023 Financial.. |
06/2/2024 | 09:24 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
01/2/2024 | 08:01 | Edgar (US Regulatory) | Form 8-K - Current report |
23/1/2024 | 07:00 | GlobeNewswire Inc. | NAYA Biosciences To Acquire Clinical Stage Gene Therapy.. |
17/1/2024 | 07:00 | GlobeNewswire Inc. | INVO Bioscience Files S-4 Registration and Preliminary Joint.. |
16/1/2024 | 16:29 | Edgar (US Regulatory) | Form S-4 - Registration of securities, business combinations |
10/1/2024 | 15:46 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
10/1/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos INVO
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.9179 | 1.24 | 0.9077 | 1.13 | 280,645 | 0.1221 | 13.30% |
1 Month | 1.59 | 1.71 | 0.85 | 1.30 | 612,045 | -0.55 | -34.59% |
3 Months | 0.9063 | 3.50 | 0.70 | 1.78 | 4,110,194 | 0.1337 | 14.75% |
6 Months | 1.83 | 3.50 | 0.70 | 1.78 | 2,064,513 | -0.79 | -43.17% |
1 Year | 7.00 | 8.60 | 0.50 | 2.22 | 2,377,597 | -5.96 | -85.14% |
3 Years | 79.40 | 108.552 | 0.50 | 3.79 | 831,483 | -78.36 | -98.69% |
5 Years | 63.40 | 246.00 | 0.50 | 31.03 | 855,070 | -62.36 | -98.36% |